AN2 Therapeutics, Inc.
ANTX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $18,003 | $18,220 | $19,985 | $21,351 |
| Short-Term Investments | $43,918 | $44,696 | $47,075 | $62,267 |
| Receivables | $0 | $2,700 | $0 | $300 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2,095 | $1,908 | $300 | $2,344 |
| Total Curr. Assets | $64,016 | $67,524 | $69,559 | $86,262 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $3,219 | $8,301 | $11,480 | $5,021 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $304 | $804 |
| Total NC Assets | $3,219 | $8,301 | $11,784 | $5,825 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $67,235 | $75,825 | $81,343 | $92,087 |
| Liabilities | – | – | – | – |
| Payables | $2,226 | $2,113 | $3,073 | $3,317 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | -$1,199 | $369 | $2,467 |
| Total Curr. Liab. | $2,226 | $2,113 | $8,014 | $10,238 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $4,632 | $4,870 | $0 | $0 |
| Total NC Liab. | $4,632 | $4,870 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $6,858 | $6,983 | $8,014 | $10,238 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$232,240 | -$222,887 | -$216,425 | -$205,776 |
| AOCI | $0 | $25 | $48 | $31 |
| Other Equity | $292,617 | $0 | -$0 | $0 |
| Total Equity | $60,377 | $68,842 | $73,329 | $81,849 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $67,235 | $75,825 | $81,343 | $92,087 |
| Net Debt | -$18,003 | -$18,220 | -$19,985 | -$21,351 |